Endpoints: Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs
NEW! Test-Time Scaling for De Novo Antibody Design
Read our technical reportNEW! Test-Time Scaling for De Novo Antibody Design
Read our technical report